• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neurooncol. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for

tetano

Editor, Senior Moderator
J Neurooncol. 2020 Apr 9. doi: 10.1007/s11060-020-03488-7. [Epub ahead of print]
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.


Ramakrishna R[SUP]1[/SUP], Zadeh G[SUP]2[/SUP], Sheehan JP[SUP]3[/SUP], Aghi MK[SUP]4[/SUP].

Author information




Abstract

The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.



KEYWORDS:

Acoustic neuroma; Brain metastasis; COVID19; Coronavirus; Endoscopic endonasal; Glioblastoma; Glioma; Meningioma; Neuro-oncology; Neurosurgery; SARS-CoV-2; Skull base


PMID:32274630DOI:10.1007/s11060-020-03488-7
 
Back
Top Bottom